IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 12 February 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01789-06v1
75/5/2591    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sebastian, S.
Right arrow Articles by Kasper, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sebastian, S.
Right arrow Articles by Kasper, D. L.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01789-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

A defined O-antigen polysaccharide mutant of Francisella tularensis LVS has attenuated virulence while retaining its protective capacity

Shite Sebastian, Simon T. Dillon, Jillian G. Lynch, LeeAnn T. Blalock, Emmy Balon, Kristin T. Lee, Laurie E. Comstock, J. Wayne Conlan, Eric J. Rubin, Arthur O. Tzianabos, and Dennis L. Kasper*

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA; National Research Council Canada, Institute for Biological Sciences, Ottawa, Ont., Canada KIA OR6

* To whom correspondence should be addressed. Email: dennis_kasper{at}hms.harvard.edu.


   Abstract

Francisella tularensis, the causative agent of tularemia, has been designated a CDC category A select agent because of its low infective dose (< 10 colony-forming units), its ready transmission by aerosol, and its ability to produce severe morbidity and high mortality. The identification and characterization of this organism's virulence determinants will facilitate the development of a safe and effective vaccine. We report that inactivation of the wbtA-encoded dehydratase of the O-antigen polysaccharide (O-PS) locus of the still-unlicensed live vaccine strain of F. tularensis (LVS) results in a mutant (Ft.LVS::wbtA) with remarkably attenuated virulence. Western blot analysis and immune electron microscopy studies associate this loss of virulence with a complete lack of surface O-PS expression. A likely mechanism for attenuation is shown to be the transformation from serum resistance in the wild-type strain to serum sensitivity in the mutant. Despite this significant attenuation in virulence, the Ft.LVS::wbtA mutant remains immunogenic and confers protective immunity to mice against challenge with an otherwise-lethal dose of either F. tularensis LVS or a fully virulent clinical isolate of F. tularensis type B. Recognition and characterization of the pivotal role of O-PS in the virulence of this intracellular bacterial pathogen may have broad implications for the creation of a safe and efficacious vaccine.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.